Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bonnefont-Rousselot

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Clinical Laboratory|October 17, 2017
Impact of pH on Urine Chemistry Assayed on Roche AnalyzersR Cohen, R Alkouri, I Tostivint, et al.
International Journal of Cardiology|October 30, 2012
Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatmentsJ C Charniot, R Khani-Bittar, J P Albertini, et al.
The Journal of Antimicrobial Chemotherapy|January 8, 2010
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patientsM A Valantin, R Bittar, P de Truchis, et al.
Journal of Medicinal Chemistry|April 11, 1997
Novel indole-2-carboxamide and cycloalkeno[1,2-b]indole derivatives. Structure-activity relationships for high inhibition of human LDL peroxidationC Kuehm-Caubere, P Caubere, B Jamart-Gregoire, et al.
Neurology|January 18, 2008
Dyslipidemia is a protective factor in amyotrophic lateral sclerosisL Dupuis, P Corcia, A Fergani, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Clinical Laboratory|October 17, 2017
Impact of pH on Urine Chemistry Assayed on Roche AnalyzersR Cohen, R Alkouri, I Tostivint, et al.
International Journal of Cardiology|October 30, 2012
Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatmentsJ C Charniot, R Khani-Bittar, J P Albertini, et al.
The Journal of Antimicrobial Chemotherapy|January 8, 2010
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patientsM A Valantin, R Bittar, P de Truchis, et al.
Journal of Medicinal Chemistry|April 11, 1997
Novel indole-2-carboxamide and cycloalkeno[1,2-b]indole derivatives. Structure-activity relationships for high inhibition of human LDL peroxidationC Kuehm-Caubere, P Caubere, B Jamart-Gregoire, et al.
Neurology|January 18, 2008
Dyslipidemia is a protective factor in amyotrophic lateral sclerosisL Dupuis, P Corcia, A Fergani, et al.
Pageof 8